 <h1>Enoxaparin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of enoxaparin include:</b> anemia and hemorrhage. <b>Other side effects include:</b> fever.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to enoxaparin: solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>Epidural or spinal hematomas, which may result in long-term or permanent paralysis, may occur in patients who are anticoagulated with low molecular weight heparins or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. Factors that can increase the risk of developing these hematomas include: use of indwelling epidural catheters, concomitant use of drugs affecting hemostasis such as NSAIDs, platelet inhibitors, or other anticoagulants, or history of traumatic or repeated epidural or spinal puncture, spinal deformity, or spinal surgery. Optimal timing between the administration of enoxaparin sodium and neuraxial procedures is not known. Monitor patients frequently for neurological impairment. If neurological compromise is noted, urgent treatment is necessary. Consider risks/benefits before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, enoxaparin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking enoxaparin:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding gums</li>
<li>coughing up blood</li>
<li>difficulty with breathing or swallowing</li>
<li>dizziness</li>
<li>headache</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>nosebleeds</li>
<li>paralysis</li>
<li>prolonged bleeding from cuts</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>shortness of breath</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bruising</li>
<li>chest discomfort</li>
<li>collection of blood under the skin</li>
<li>confusion</li>
<li>continuing bleeding or oozing from the nose and/or mouth, or surgical wound</li>
<li>convulsions (seizures)</li>
<li>fever</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>lower back pain</li>
<li>pain or burning while urinating</li>
<li>swelling of the hands or feet</li>
<li>tightness in the chest</li>
<li>uncontrolled bleeding at the site of injection</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>wheezing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Back pain</li>
<li>burning, pricking, tickling, or tingling sensation</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>decreased urine output</li>
<li>dilated neck veins</li>
<li>dizziness or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>extreme fatigue</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>general feeling of discomfort or illness</li>
<li>irregular breathing</li>
<li>leg weakness</li>
<li>problems with bowel or bladder function</li>
<li>skin rash or hives</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sudden fainting</li>
<li>swelling of the face, fingers, feet, genitals, mouth, or tongue</li>
<li>thickening of the bronchial secretions</li>
<li>troubled breathing</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>deep, dark purple bruise</li>
<li>hives or welts</li>
<li>irregular heartbeat</li>
<li>itching, pain, redness, or swelling</li>
<li>large, flat, blue, or purplish patches in the skin</li>
<li>nausea or vomiting</li>
<li>nervousness</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>skin rash</li>
<li>unusual tiredness or weakness</li>
<li>weakness or heaviness of the legs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of enoxaparin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>irritation, pain, or redness at the place of injection</li>
</ul><p>
<!-- end solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to enoxaparin: injectable solution</i></p><h3>General</h3><p>The most common adverse reactions were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, and nausea.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Major hemorrhage</p>
<p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, heart failure</p>
<p><b>Frequency not reported</b>: Hemorrhage</p>
<p><b>Postmarketing reports</b>: Shock, valve thrombosis in patients with prosthetic heart valves<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, anemia, platelet counts between 100,000 and 50,000/mm3</p>
<p><b>Uncommon</b> (0.1% to 1%): Platelet counts less than 50,000/mm3</p>
<p><b>Frequency not reported</b>: Thrombocytosis</p>
<p><b>Postmarketing reports</b>: Hemorrhagic anemia, platelet count increased, eosinophilia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased asymptomatically, AST increased asymptomatically</p>
<p><b>Frequency not reported</b>: Hepatic enzymes increased</p>
<p><b>Postmarketing reports</b>: Hepatocellular liver injury, cholestatic liver injury<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Retroperitoneal hemorrhage<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site hematoma, injection site pain, other injection site reaction</p>
<p><b>Uncommon</b> (0.1% to 1%): Local irritation, injection site skin necrosis</p>
<p><b>Postmarketing reports</b>: Injection site nodules<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Urticaria, pruritus, erythema</p>
<p><b>Uncommon</b> (0.1% to 1%): Bullous dermatitis</p>
<p><b>Postmarketing reports</b>: Cutaneous vasculitis, skin necrosis, alopecia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Peripheral edema, edema</p>
<p><b>Rare</b> (less than 0.1%): Hyperkalemia</p>
<p><b>Postmarketing reports</b>: Hyperlipidemia, hypertriglyceridemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p>
<p><b>Rare</b> (0.01% to 0.1%): Anaphylactic/anaphylactoid reaction</p>
<p><b>Very rare</b> (less than 0.01%): Immuno-allergic thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Immuno-allergic thrombocytopenia with thrombosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Lung edema, pneumonia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fever<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Intracranial hemorrhage</p>
<p><b>Postmarketing reports</b>: Headache, spinal hematoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Osteoporosis following treatment longer than 3 months<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Lovenox (enoxaparin)." Rhone-Poulenc Rorer, Collegeville, PA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about enoxaparin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>22 Reviews</li>
<li>Drug class: heparins</li>
<li>FDA Alerts (2)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Enoxaparin Subcutaneous, Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Lovenox</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Deep Vein Thrombosis</li>
<li>Deep Vein Thrombosis Prophylaxis after Abdominal Surgery</li>
<li>Acute Coronary Syndrome</li>
<li>Angina</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to enoxaparin: injectable solution</i></p><h3>General</h3><p>The most common adverse reactions were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, and nausea.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Major hemorrhage</p><p><b>Uncommon</b> (0.1% to 1%): Atrial fibrillation, heart failure</p><p><b>Frequency not reported</b>: Hemorrhage</p><p><b>Postmarketing reports</b>: Shock, valve thrombosis in patients with prosthetic heart valves<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, anemia, platelet counts between 100,000 and 50,000/mm3</p><p><b>Uncommon</b> (0.1% to 1%): Platelet counts less than 50,000/mm3</p><p><b>Frequency not reported</b>: Thrombocytosis</p><p><b>Postmarketing reports</b>: Hemorrhagic anemia, platelet count increased, eosinophilia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased asymptomatically, AST increased asymptomatically</p><p><b>Frequency not reported</b>: Hepatic enzymes increased</p><p><b>Postmarketing reports</b>: Hepatocellular liver injury, cholestatic liver injury<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Retroperitoneal hemorrhage<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site hematoma, injection site pain, other injection site reaction</p><p><b>Uncommon</b> (0.1% to 1%): Local irritation, injection site skin necrosis</p><p><b>Postmarketing reports</b>: Injection site nodules<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Urticaria, pruritus, erythema</p><p><b>Uncommon</b> (0.1% to 1%): Bullous dermatitis</p><p><b>Postmarketing reports</b>: Cutaneous vasculitis, skin necrosis, alopecia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Peripheral edema, edema</p><p><b>Rare</b> (less than 0.1%): Hyperkalemia</p><p><b>Postmarketing reports</b>: Hyperlipidemia, hypertriglyceridemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic/anaphylactoid reaction</p><p><b>Very rare</b> (less than 0.01%): Immuno-allergic thrombocytopenia</p><p><b>Postmarketing reports</b>: Immuno-allergic thrombocytopenia with thrombosis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Lung edema, pneumonia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusion<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fever<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Intracranial hemorrhage</p><p><b>Postmarketing reports</b>: Headache, spinal hematoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Postmarketing reports</b>: Osteoporosis following treatment longer than 3 months<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Lovenox (enoxaparin)." Rhone-Poulenc Rorer, Collegeville, PA. </p><h2>More about enoxaparin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>22 Reviews</li>
<li>Drug class: heparins</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Enoxaparin Subcutaneous, Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Deep Vein Thrombosis</li>
<li>Deep Vein Thrombosis Prophylaxis after Abdominal Surgery</li>
<li>Acute Coronary Syndrome</li>
<li>Angina</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>